Follow The Filings

TECH position history

The shares of Bio-Techne (TECH) that GLENVIEW CAPITAL MANAGEMENT, LLC reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2025 Q3: 374,051 shares, $21M, 0.46% of portfolio, New
  2. 2025 Q4: 619,944 shares, $36M, 0.74% of portfolio, Add +65.7%
  3. 2026 Q1: 186,312 shares, $9.7M, 0.24% of portfolio, Reduce −69.9%
  4. 2026 Q2: 58,324 shares, $4.1M, 0.08% of portfolio, Reduce −68.7%
Holdings date Value % of holdings Shares Filing date All 13F holders